Keyword :   PARP-inhibitors

The role of molecular genetic tests in the treatment of ovarian cancer. Folate receptors as an important therapeutic target in modern oncogynecology. Review of the scientific literature
Authors: Zlenko M.O. Svintsitskyi V.S. Yatsyna O.I. Дата: 2026-06-10
Modern approaches to the treatment of advanced ovarian cancer in the 1st line therapy (PAOLA-1 study) and recurrent ovarian cancer regardless of the presence of BRCA mutations, as well as modern cytoreductive approaches (based on materials from the ESGO 2025 Congress)
Т. 15, №2 (58)
A Multidisciplinary Approach to Breast Cancer Treatment in Historical Perspective
Т. 14, №4 (56)
New stage in personalized breast cancer therapy: a chance for recovery
Т. 13, №4 (52)
Talazoparib in the treatment of breast cancer. Analysis of the real-world evidence
Т. 13, № 3 (51)
New stage in personalized breast cancer therapy: a chance for recovery
Т. 13, № 3 (51)
Pancreatic Cancer: Innovations For Life
Т. 13, № 1 (49)
Oncourology. The latest technologies in today’s realities: the results of the PROfound study — the efficacy and safety profile of olaparib in mCRPC
Т. 12, № 3-4 (47-48)
Breast cancer: innovations for life. Part 2
Дата: 2022-09-01
Breast cancer: innovations for life. Part 1
Т. 12, № 1-2 (45-46)